Effects of potential probiotic Bacillus velezensis K2 on growth, immunity and resistance to Vibrio harveyi infection of hybrid grouper (Epinephelus lanceolatus♂ × E. fuscoguttatus♀)

• Published in: Fish & shellfish immunology Vol. 93; pp. 1047 - 1055
• Main Authors: Li, Jing, Wu, Zhi-Bin, Zhang, Zhao, Zha, Ji-Wei, Qu, Shen-Ye, Qi, Xiao-Zhou, Wang, Gao-Xue, Ling, Fei
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2019
• Subjects: acid phosphatase; Aeromonas hydrophila; Aeromonas punctata; Aeromonas veronii; Animal Feed - analysis; Animals; Antibacterial activity; Bacillus - chemistry; Bacillus velezensis; bacteria; Bass - growth & development; Bass - immunology; blood serum; death; Diet - veterinary; dietary supplements; disease resistance; Disease Resistance - immunology; Enterococcus casseliflavus; Epinephelus; females; fish culture; fish diseases; Fish Diseases - immunology; gene expression; gene expression regulation; genes; grouper; Growth performance; health status; Hybrid grouper; hybrids; immunity; immunoglobulin M; intestines; intraperitoneal injection; kidneys; Lactococcus garvieae; lysozyme; males; messenger RNA; pathogens; Probiotics; Probiotics - pharmacology; Random Allocation; Resistance; survival rate; Toll-like receptor 3; Toll-like receptor 5; Vibrio - drug effects; Vibrio - physiology; Vibrio alginolyticus; Vibrio harveyi; Vibrio Infections - immunology; Vibrio Infections - veterinary; vibriosis; Resistance; Probiotics; Antibacterial activity; Hybrid grouper; Growth performance; Bacillus velezensis
• ISSN: 1050-4648; 1095-9947; 1095-9947
• DOI: 10.1016/j.fsi.2019.08.047

Nowadays, there is no suitable treatment for vibriosis in groupers. So an eco-efficient and environmentally friendly treatment is necessary for the grouper industry. Probiotic-feeding has been a promising strategy to control the bacterial pathogens in aquaculture. A new Bacillus velezensis strain named K2 was isolated from the intestinal tract of healthy grouper, and exhibited wide antimicrobial spectrum of against fish pathogens, including Vibrio harveyi, Vibrio alginolyticus, Aeromonas hydrophila, Aeromonas veronii, Aeromonas caviae, Enterococcus casseliflavus and Lactococcus garvieae. Moreover, results of the safety of B. velezensis K2 showed that intraperitoneal injection of K2 in healthy grouper did not cause any pathological abnormality or death, indicating this bacteria could be considered as a candidate probiotic in aquaculture. Groupers were fed with the diets containing 1 × 107 cfu/g of B. velezensis K2 for 4 weeks. Various immune parameters were examined at 1, 2, 3, and 4 weeks of post-feeding. Results showed that diets supplemented with K2 significantly increased serum acid phosphatase (ACP) activity (P < 0.05). Results of the mRNA expression of immune-related genes in the head kidney of hybrid grouper showed that the expression of lysozyme gene was significantly upregulated after 1 and 2 weeks of feeding (P < 0.05). A significant up-regulation of the expression of piscidin, IgM and MyD88 were detected at day 21, whereas the TLR3 and TLR5 showed lower expression compared to the controls during 21 days, and a significant decrease of TLR3 gene was found at day 28 (P < 0.05). After challenge with V. harveyi, the survival rate of fish administrated with the strain K2 for 28 days was signifiacantly higher than the controls without this strain (P < 0.05). These results collectively suggest that B. velezensis K2 is a potential probiotic species to improve health status and disease resistance and can be developed as a probiotic agent in grouper industry. •Bacillus velezensis strain K2 was isolated from the intestinal tract of healthy hybrid grouper.•B. velezensis K2 possesses prominent probiotic properties.•B. velezensis K2-supplemented diets enhanced immune responses of hybrid grouper.•B. velezensis K2-supplemented diets increased the resistance against V. harveyi.